Clinical Trial Detail

NCT ID NCT04013542
Title Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Ipilimumab + Nivolumab

Nivolumab

Age Groups: senior adult

Additional content available in CKB BOOST